CT reshapes imaging in the heart and beyond
New imaging technologies and applications sometimes slide into practice without making many ripples. It takes a while for imagers to widely adopt the latest advance, or the protocols haven't been worked out yet, or it essentially allows imagers to do the same things they did before, but with more clarity or speed.
Cardiovascular CT, by contrast, seems to be making the sort of cannonball splash that's hard to miss. This supplement to Diagnostic Imaging is the first in a two-part series to evaluate how CT is changing cardiovascular imaging. In the following pages, we look at CT's role in peripheral vessel imaging and interventional planning. While two specialties are vying for the right to perform and interpret the studies made possible by the latest generations of CT scanners, we look at the education necessary to make those reads accurate, and how enterprising radiologists, in turn, are trying to educate their referral base in order to build up a new practice niche.
Keep an eye out for Part 2 in February, which will look at plaque evaluation, trauma, and the all-important question of securing reimbursement.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
